insights_auto
Why is AKBA down 13,20%?
Dive Deeperchevron_right
AKBA:NASDAQ
Akebia Therapeutics Inc
US$0,50
arrow_downward
-13,20%(-0,076) 1D
US$0,49
arrow_downward
-1,61% (-0,0080)todayPre-market
Closed: 12 ພ.ຈ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AKBA...
Open
US$0,57
High
US$0,57
Low
US$0,50
Mkt. cap
139,17 ລ້ານ
Avg. vol.
8,81 ລ້ານ
Volume
4,56 ພັນ
52-wk high
US$1,84
52-wk low
US$0,36
EPS
US$-0,16
Beta
0,24
Shares outstanding
277,66 ລ້ານ
No. of employees
194
Open
US$0,57
High
US$0,57
Low
US$0,50
Mkt. cap
139,17 ລ້ານ
Avg. vol.
8,81 ລ້ານ
Volume
4,56 ພັນ
52-wk high
US$1,84
52-wk low
US$0,36
EPS
US$-0,16
Beta
0,24
Shares outstanding
277,66 ລ້ານ
No. of employees
194
News stories
From web sources and news partners
Barron's
·
14 ນາທີກ່ອນ
S&P 500 Futures Up in Premarket Trading; Modine Manufacturing, Cerebras Systems Lead
Seeking Alpha
·
14 ນາທີກ່ອນ
Buckle Up - The S&P 500 Is Failing The Oldest Test In Investing
Investing.com
·
8 ນາທີກ່ອນ
Goldman’s Oppenheimer sees S&P 500 advancing to 8,700 in 2027
Reuters
·
1 ຊົ່ວໂມງກ່ອນ
Nasdaq futures dip as Nvidia tumult keeps investors on edge
About Akebia Therapeutics Inc
CEO-
Employees194
Founded1 ມ.ກ. 2007
Headquartersແຄມບຣິກ, ມາຊາຊູເຊັດ, ສະຫະລັດ
SectorHealth Care
IndustryBiotechnology
Websiteakebia.com